Armata Pharmaceuticals Inc (ARMP)
2.34
-0.02
(-0.85%)
USD |
NYAM |
Nov 04, 13:03
Armata Pharmaceuticals Total Assets (Quarterly): 108.31M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 108.31M |
March 31, 2024 | 120.36M |
December 31, 2023 | 98.36M |
September 30, 2023 | 112.76M |
June 30, 2023 | 101.21M |
March 31, 2023 | 108.78M |
December 31, 2022 | 95.83M |
September 30, 2022 | 92.88M |
June 30, 2022 | 100.98M |
March 31, 2022 | 107.76M |
December 31, 2021 | 69.77M |
September 30, 2021 | 42.67M |
June 30, 2021 | 48.28M |
March 31, 2021 | 52.84M |
December 31, 2020 | 39.52M |
September 30, 2020 | 45.68M |
June 30, 2020 | 49.46M |
March 31, 2020 | 44.10M |
December 31, 2019 | 25.45M |
September 30, 2019 | 29.30M |
June 30, 2019 | 34.92M |
March 31, 2019 | 9.617M |
December 31, 2018 | 11.89M |
September 30, 2018 | 10.62M |
June 30, 2018 | 11.72M |
Date | Value |
---|---|
March 31, 2018 | 14.40M |
December 31, 2017 | 11.14M |
September 30, 2017 | 13.78M |
June 30, 2017 | 15.11M |
March 31, 2017 | 14.30M |
December 31, 2016 | 18.15M |
September 30, 2016 | 26.04M |
June 30, 2016 | 29.28M |
March 31, 2016 | 28.26M |
December 31, 2015 | 31.49M |
September 30, 2015 | 34.08M |
June 30, 2015 | 36.37M |
March 31, 2015 | 38.60M |
December 31, 2014 | 28.62M |
September 30, 2014 | 28.42M |
June 30, 2014 | 31.26M |
March 31, 2014 | 34.35M |
December 31, 2013 | 41.21M |
September 30, 2009 | 4.53M |
June 30, 2009 | 4.077M |
March 31, 2009 | 5.471M |
December 31, 2008 | 7.15M |
September 30, 2008 | 19.18M |
June 30, 2008 | 22.71M |
March 31, 2008 | 24.25M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
25.45M
Minimum
Dec 2019
120.36M
Maximum
Mar 2024
77.11M
Average
92.88M
Median
Sep 2022
Total Assets (Quarterly) Benchmarks
AIM ImmunoTech Inc | 15.72M |
Perspective Therapeutics Inc | 385.92M |
Protalix BioTherapeutics Inc | 91.54M |
Electromed Inc | 52.23M |
Xtant Medical Holdings Inc | 95.58M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 154.41M |
Shareholders Equity (Quarterly) | -46.10M |